DO ATHEROSCLEROTIC EVENTS CHANGE LIPID LOWERING THERAPY USE IN CLINICAL PRACTICE? - THE ANSWER WITH REAL-WORLD DATA
Autores da FMUP
Participantes de fora da FMUP
- Seabra, D
- Afonso-Silva, M
- Grangeia, D
Unidades de investigação
Abstract
Abstract no disponible
Filiações
Filiações não disponíveis
Campos de estudo
Proyectos asociados
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846
Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes
Estudo Observacional Académico (F-CHECK) . Sanofi . 2022
Citar a publicação
Seabra,D,Araújo,F,Afonso,M,Grangeia,D,Taveira,T,Gavina,C. DO ATHEROSCLEROTIC EVENTS CHANGE LIPID LOWERING THERAPY USE IN CLINICAL PRACTICE? - THE ANSWER WITH REAL-WORLD DATA. 90th Congress of the European-Atherosclerosis-Society (EAS). 2022. Milan-ITALY. ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND:Elsevier Ireland Ltd. 2022 p.p. 75-75.